Table 1.
Clinical management and serum samples availability of 162 COVID-19 study patients.
| Clinical management | No. of patients | No. of patients with serum samples at visit performed | |
|---|---|---|---|
| In-hospital | Outpatient clinic | ||
| Admitted to the Emergency Department | 150 (92.6%) | ||
| Discharged (not hospitalized) | 16 (10.7%) | 16 | 9 |
| Hospitalized | 134 (89.3%) | ||
| ≤7days | 25 (18.7%) | 25 | 19 |
| >7days | 65 (48.5%) | 65 | 44 |
| deceased | 18 (13.4%) | 18 | na |
| in need of ICU, recovered | 15 (11.2%) | 15 | 2 |
| in need of ICU, decease | 11 (8.2%) | 11 | na |
| Admitted at the COVID-19 outpatient clinic | 12 (7.4%) | ||
| Not hospitalized | 10 | na | 3 |
| Hospitalized | 2 | na | 2 |
ICU Intensive Care Unit, na not applicable
A dedicated serum sample was collected during attendance at the hospital, which took place either at the Emergency Department or at the ward (called the in-hospital sample). Follow-up serum samples were collected at the COVID-19 outpatient clinic during the 1, 3 and 6 months visits after discharge